Can a health advocate prevent organ rejection in kids after liver transplant?
NCT ID NCT07279350
First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times
Summary
This study tests whether a health advocate can help families of children who recently had a liver transplant. The advocate works with the family for 90 days to find resources, coordinate appointments, and communicate concerns to the medical team. The goal is to see if this support reduces organ rejection and improves outcomes. About 108 families will take part, with half receiving the advocate and half getting a resource handout.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- health advocate (behavioural intervention)
- What this could lead to
- If it works, this could show that a health advocate helps families manage care after a child's liver transplant, potentially reducing organ rejection and improving long-term health.
- What could go wrong
- This is a small, early-stage trial with only 108 participants, so results may not apply to everyone. The intervention is short (90 days) and may not have lasting effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC LIVER TRANSPLANTED RECIPIENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94158, United States
-
University of Pittsburgh Medical Center | Children Hospital of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15224, United States